Evidence map›Paper›PMID 24389162›Full record

ReviewAdvanced drug delivery reviews2014

State-of-the-art materials for ultrasound-triggered drug delivery.

Shashank R Sirsi, Mark A Borden

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 164 papers.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Acoustically Activatable Drug-Loaded Nanodroplets for Mechanochemical Therapy in Solid Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. The Immune Microenvironment in Liver Cancer: From Analysis to Targeting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  18. Review
  19. Review
  20. Article

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shashank R SirsiDepartment of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA.
Mark A BordenDepartment of Mechanical Engineering, University of Colorado, Boulder, CO 80309, USA; Materials Science and Engineering Program, University of Colorado, Boulder, CO 80309, USA. Electronic address: mark.borden@colorado.edu.

Funding

Microbubble Infused Hydrogels for Cartilage Tissue EngineeringR21EB014382 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BORDEN, MARK ANDREW, HUNG, CLARK T. · 2011 to 2012
$606k
Quantitative Monitoring and Control of Tumor Vascular Permeability in vivo UsingR21EB015040 · NIBIB · UNIVERSITY OF COLORADO · PI BORDEN, MARK ANDREW, KANDEL, JESSICA J · 2012 to 2013
$418k
NIBIB NIH HHS 1R21EB015040-01A1NIBIB NIH HHS R21 EB014382NIBIB NIH HHS R21 EB015040
6 · The paper itself

Abstract

Ultrasound is a unique and exciting theranostic modality that can be used to track drug carriers, trigger drug release and improve drug deposition with high spatial precision. In this review, we briefly describe the mechanisms of interaction between drug carriers and ultrasound waves, including cavitation, streaming and hyperthermia, and how those interactions can promote drug release and tissue uptake. We then discuss the rational design of some state-of-the-art materials for ultrasound-triggered drug delivery and review recent progress for each drug carrier, focusing on the delivery of chemotherapeutic agents such as doxorubicin. These materials include nanocarrier formulations, such as liposomes and micelles, designed specifically for ultrasound-triggered drug release, as well as microbubbles, microbubble-nanocarrier hybrids, microbubble-seeded hydrogels and phase-change agents.

Indexed as

Drug Delivery SystemsAnimalsHydrogelsMicrobubblesUltrasonicsHydrogelsLiposomesMicellesMicrobubblesPhase-change agentsTargeted drug delivery

Identifiers

PMID24389162
PMCPMC4041842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.